New antiviral treatment for COVID-19 will be mostly set aside for use in older unvaccinated individuals and immunocompromised Ontarians
A new antiviral drug that can be used to treat COVID-19 will be primarily set aside for use in older unvaccinated individuals and immunocompromised Ontarians.
The Ford government has released new eligibility guidelines that provide the first look at how it will distribute its limited supply of Pfizer’s Paxlovid pill, the first shipment of which arrived in the province last week.
The government says that it is prioritizing individuals at “the highest risk of severe outcomes,” including unvaccinated Ontarians age 60 and up and unvaccinated Ontarians aged 50 and up who also have one or more specific risk factors.
The government will also make all immunocompromised individuals aged 18 and up eligible, regardless of their vaccination status, as well as all unvaccinated First Nation, Inuit and Métis individuals aged 50 and up.
In order to access the drug those eligible will have to first test positive for COVID-19 and the Ford government says that it is now introducing “expanded COVID-19 assessment centres” where Ontarians will be able to access both testing and “outpatient therapeutics,” such as Paxlovid.
It says that the testing centres will have access to multiple testing options, including rapid tests, to asses those who may be eligible for treatment.
However, not all assessment centres will have the drug on hand.
According to data from the clinical trials, the Paxlovid pill was found to be 89 per cent effective at reducing the risk of hospitalization and death after a full course of treatment (three pills twice daily for five days in a row).
The Ontario government has said that it expects to receive approximately 10,000 courses of treatment in January.
“Given the very limited supply of antivirals, not all patients who meet the clinical eligibility criteria will be guaranteed access to treatment,” the government warns on a new website set up to provide information about antiviral treatments.
Paxlovid was approved by Health Canada on Jan. 17.
CTVNews.ca Top Stories
MPP Sarah Jama asked to leave Ontario legislature for wearing keffiyeh
MPP Sarah Jama was asked to leave the Legislative Assembly of Ontario by House Speaker Ted Arnott on Thursday for wearing a keffiyeh, a garment which has been banned at Queen’s Park.
Mountain guide dies after falling into a crevasse in Banff National Park
A man who fell into a crevasse while leading a backcountry ski group deep in the Canadian Rockies has died.
2 teens charged in Halifax homicide: police
Two teenagers have been charged with second-degree murder in connection to an alleged homicide near the Halifax Shopping Centre earlier this week.
'Deep ignorance': Calls for Manitoba trustee to resign sparked after comments about Indigenous people and reconciliation
A rural Manitoba school trustee is facing calls to resign over comments he made about Indigenous people and residential schools earlier this week.
12-year-old hippo in Japan raised as a male discovered to be a female
When Gen-chan arrived at a zoo in Japan in 2017, no one questioned whether the then-five-year-old hippopotamus was a boy. Seven years later, zoo staff made a surprising discovery: Gen-chan, now 12, was female.
Here's why Harvey Weinstein's New York rape conviction was tossed and what happens next
Here's what you need to know about why movie mogul Harvey Weinstein's rape conviction was thrown out and what happens next.
Legendary hockey broadcaster Bob Cole dies at 90: CBC
Bob Cole, a welcome voice for Canadian hockey fans for a half-century, has died at the age of 90. Cole died Wednesday night in St. John's, N.L., surrounded by his family, his daughter, Megan Cole, told the CBC.
Humanist group threatening to sue Vancouver over council prayers
The B.C. Humanist Association has threatened legal action against the City of Vancouver for allowing prayers at council, following a similar warning issued earlier this month to a smaller community on Vancouver Island.
LHSC performs a Canadian first in robot-assisted direct lateral spine surgery
Spine surgery may never be the same for people with chronic back pain and other physical ailments.